Proteomics

Dataset Information

0

Proteomic characterization of CD34+ CD123+ stem cells from patients with acute myeloid leukemia


ABSTRACT: The comparative characterization of hematopoietic stem cells from healthy stem cell donors and patients with acute myeloid leukemia on a proteome level has the potential to reveal differentially regulated proteins which might be candidates for specific immunotherapy target molecules. Exemplarily, we analyzed the proteome of the cytosolic and the membrane fraction of CD34 and CD123 co-expressing FACS-sorted leukemic progenitors from five patients with acute myeloid leukemia employing mass spectrometry. As a reference, CD34+CD123+ normal hematopoietic progenitor cells from five healthy stem cell donors were analyzed. In this TMT 10-plex labeling based approach 2068 proteins were identified with 256 proteins differentially regulated in one or both cellular compartments. This study demonstrates the feasibility of a mass spectrometry based proteomic approach to detect differentially expressed proteins in two compartment fractions of leukemic stem cells as compared to their healthy stem cell counterparts.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell, Stem Cell, Blood

DISEASE(S): Acute Leukemia

SUBMITTER: Johannes R. Schmidt  

LAB HEAD: Martin von Bergen

PROVIDER: PXD008378 | Pride | 2018-02-19

REPOSITORIES: Pride

altmetric image

Publications

Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.

Schmidt Johannes R JR   Rücker-Braun Elke E   Heidrich Katharina K   von Bonin Malte M   Stölzel Friedrich F   Thiede Christian C   Middeke Jan M JM   Ehninger Gerhard G   Bornhäuser Martin M   Schetelig Johannes J   Schubert Kristin K   von Bergen Martin M   Heidenreich Falk F  

Proteomes 20180212 1


Targeting of leukemic stem cells with specific immunotherapy would be an ideal approach for the treatment of myeloid malignancies, but suitable epitopes are unknown. The comparative proteome-level characterization of hematopoietic stem and progenitor cells from healthy stem cell donors and patients with acute myeloid leukemia has the potential to reveal differentially expressed proteins which can be used as surface-markers or as proxies for affected molecular pathways. We employed mass spectrome  ...[more]

Similar Datasets

| E-GEOD-9476 | biostudies-arrayexpress
2021-03-31 | GSE165870 | GEO
| E-GEOD-49665 | biostudies-arrayexpress
2022-07-20 | PXD022754 | Pride
| phs000549 | dbGaP
2018-02-28 | GSE102881 | GEO
| E-GEOD-11675 | biostudies-arrayexpress
| E-GEOD-37307 | biostudies-arrayexpress
| E-MTAB-2672 | biostudies-arrayexpress
| E-MTAB-8884 | biostudies-arrayexpress